Information Provided By: 
Fly News Breaks for September 17, 2017
MD
Sep 17, 2017 | 20:45 EDT
KeyBanc analyst Jason Gurda upgraded MEDNAX to Overweight with a $51 price target. Gurda expects a moderation in operating headwinds over the next few quarters, cost cutting/new revenue to offset some of the headwinds, thinks the radiology business is poised for strong growth, and views the company as a potential acquisition target over the next few years.
News For MD From the Last 2 Days
There are no results for your query MD
